Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis

By afschroeder • June 25, 2025

Todd JL, Page C, Wu P, Belperio JA, Maher TM, Palmer SM, Leonard TB, Hesslinger C, Neely ML, Schlange T. Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2025 Jun 23;11(3):00738-2024. doi: 10.1183/23120541.00738-2024. PMID: 40551789; PMCID: PMC12183712.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Association Between Ultraprocessed Food Consumption and Cardiovascular Disease Risk: MESA (Multiethnic Study of Atherosclerosis)

Haidar A, Rikhi R, Watson KE, Wood AC, Shapiro MD. Association Between Ultraprocessed Food Consumption and Cardiovascular Disease Risk: MESA (Multiethnic Study of Atherosclerosis). JACC[...]

Comparing sampling approaches for assessing sub-national vaccination coverage: a pilot study in Central African Republic and the Democratic Republic of Congo

Kasonga JN, Hoff NA, Merritt S, Fandema E, Nkamba DM, Zanga-Goumet HE, Bobo E, Tangney S, Mafuta E, Bangelesa F, Babakazo P, Kokolomami J, Stahley[...]

eConsult-Integrated Care to Improve Specialty Access

Bergman J, Giboney P, Waterman B, Yee H. eConsult-Integrated Care to Improve Specialty Access. JAMA Intern Med. 2026 Mar 16. doi: 10.1001/jamainternmed.2025.8352. Epub ahead of[...]